| Market Cap | ₹859Cr |
| ROE | 28.67% |
| P/E Ratio(TTM) | 7.75 |
| EPS(TTM) | 37.66 |
| P/B Ratio | 2.20 |
| Dividend Yield | 0.85% |
| Industry P/E | 33.72 |
| Book Value | 132.83 |
| Debt to Equity | 0.29 |
| Face Value | 5 |
| Parent Organisation | Fermenta Biotech Limited |
| Managing Director | Mr. Prashant Nagre |
| BSE Symbol | 506414 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 69.56 | ||
| Neuland Laboratories | NA (0.00%) | 93.26 | ||
| Jubilant Pharmova | NA (0.00%) | 37.91 | ||
| Acutaas Chemicals | NA (0.00%) | 62.11 |